Pharmacy: underpaid and stressed? Subscription
The Pharmaceutical Journal salary and satisfaction survey 2018 provides a snapshot of the profession’s pay and working conditions.
Pregnancy problems: a guide for pharmacy Subscription
Pregnancy causes many changes to the body, some of which can result in troublesome symptoms. Here we explain what pharmacy teams can do to help women seeking advice.
Statins: the highs and the lows Subscription
Negative press seems to follow statins, the most prescribed drugs in England, despite them revolutionising cardiovascular disease prevention.
Pharmacy contracts: where the money goes Subscription
Funding for the national community pharmacy contracts in England, Scotland and Wales is distributed differently. Here is a breakdown of how the three countries fund pharmacy services.
A quick guide to medical cannabis Subscription
With medical cannabis now legal in 44 countries around the world, and the UK likely to follow suit, here is what pharmacists need to know.
NHS70: major moments in pharmacy 1948–2018 Subscription
The lives of pharmacists and the medicines they manage have changed dramatically since the NHS was created. Here, we chart the milestones that shaped the profession.
Breakdown of the OTC medicines market in Britain Subscription
The over-the-counter medicines market grew by almost 1% in 2017 to reach £2.56bn. Although pain relief remains the highest value category group, the most growth was seen in eye care and gastrointestinal products.
Hepatitis C: tackling the silent killer Subscription
About 200,000 people are living with hepatitis C in the UK, but it is estimated that around half of these remain undiagnosed. Identifying those at risk, offering tests and connecting those infected with treatment are crucial to tackling the disease.
The 2017 pharmacy salary and satisfaction survey Subscription
The Pharmaceutical Journal has surveyed Royal Pharmaceutical Society members about their salary, and how they feel about their career and the profession.
The Falsified Medicines Directive will be rolled out in Europe from February 2019 to address the threat of fake medicines and will impact the entire supply chain